从问题疫苗谈我国药品安全责任保险的发展
发布时间:2018-03-04 09:18
本文选题:药品安全 切入点:责任保险 出处:《辽宁大学》2017年硕士论文 论文类型:学位论文
【摘要】:自1978年改革开放以来,不仅我国的经济发展取得了快速的进步,我国很多事业也取得了飞快的进步,例如我国医药产业快速发展,虽然其市场化程度在不断加深,但这一进步对我国国民健康以及其他方面的影响是具有双面性的。它既有有利的一面,又有不利的一面。好的一面是,正是由于医药行业的快速发展,改善了我国人民的生活状况,人们的生活变的如此快捷与方便,这提高了居民幸福指数。但不好的一面是,有些心术不正的人可能利用这一科技,利用药品来制造麻烦,药品的安全性越来越被人们所重视。药品安全对人们来说是至关重要的,这关系着每个人的生命,不仅我们自身应该予以关注,政府也应该提高对药品安全重视度。但是,要想真正提升药品安全,必须提高个人的安全意识,只有落实到每个主体上,才能从根本上解决问题。这不仅要求国家应该制定相关法律来保证实施,同时,这也是我们每个公民的责任。本文以维护消费者的根本利益为出发点,从方方面面论述我国建立药品安全责任保险的必要性与可行性。面对频繁发生的药品安全责任事故事件,建立药品安全责任制度是势在必行的,制定的原因可以归纳为以下几种:一是对于一些质量不合格的药品给消费者带来预期之外的不良反应时,生产商是否应该承担相应的责任问题,如果生产商的确应该承担责任时,因药品服用时间过长已经无法找到生产商,这时责任该由谁负责;二是药品因本身固有的危险性的存在,对于药品质量问题的认定是很难的,在实务中认定药品质量合格与否的标准更难确定,在这方面的法律法规仍然很模糊;三是对于一些药品安全导致的事件,我国应该建立药品安全责任强制保险来避免事故发生后的纠纷问题,但是现有的法律仍然没有相关规定。本文运用多种方法相结合来研究药品安全责任保险相关问题,在此基础上,提出对策建议以推进药品安全强制责任保险的推出。
[Abstract]:Since the reform and opening up in 1978, not only has China made rapid progress in economic development, but also many undertakings in China have made rapid progress, such as the rapid development of the pharmaceutical industry in our country, although the degree of marketization is deepening. But this progress has a dual impact on our national health and other aspects. It has both advantages and disadvantages. The good side is that it is precisely because of the rapid development of the pharmaceutical industry, It has improved the living conditions of our people, and people's lives have become so fast and convenient, which has increased the happiness index of the residents. But the bad side is that some people with bad intentions may take advantage of this technology and use drugs to create trouble. People pay more and more attention to the safety of drugs. Drug safety is very important to people, which is related to the lives of everyone. Not only should we pay attention to it, but the government should also pay more attention to the safety of drugs. However, In order to really enhance drug safety, we must raise the personal safety awareness. Only by implementing it to each subject can we solve the problem fundamentally. This not only requires the state to formulate relevant laws to ensure implementation, but also, at the same time, This is also the responsibility of each of our citizens. This paper, based on the fundamental interests of consumers, discusses the necessity and feasibility of establishing drug safety liability insurance in China from all aspects. In the face of frequent incidents of drug safety liability accidents, It is imperative to establish a drug safety liability system. The reasons for the establishment can be summarized as follows: first, when some unqualified drugs bring unexpected adverse reactions to consumers, Whether the manufacturer should bear the corresponding responsibility, if the manufacturer should take the responsibility, the manufacturer can not find the manufacturer because the drug is used for too long, then who should be responsible for the responsibility; Second, because of the inherent danger of drugs, it is very difficult to identify the quality of drugs, and it is more difficult to determine the standards of drug quality in practice, and the laws and regulations in this respect are still very vague; Third, for some incidents caused by drug safety, China should establish compulsory drug safety liability insurance to avoid disputes after the accident. However, there are still no relevant provisions in the existing laws. This paper uses a variety of methods to study the related issues of drug safety liability insurance, and puts forward countermeasures and suggestions to promote the introduction of compulsory liability insurance for drug safety.
【学位授予单位】:辽宁大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:F426.72;F842.6
【参考文献】
相关期刊论文 前10条
1 吴杰;赵桂芹;;我国非寿险业承保业务间的风险分散效应研究[J];保险研究;2014年12期
2 李祝用;姚兆中;;再论交强险的制度定位——立法的缺陷、行政法规与司法解释的矛盾及其解决[J];保险研究;2014年04期
3 王云兰;阮俊慧;;地方性法规、规章的效力分析——浅析《中华人民共和国立法法》第80条、第82条、第86条[J];经济研究导刊;2011年30期
4 胡晓;周典;吴丹;张勤;张博;;公立医院取消药品加成利弊分析[J];中国卫生事业管理;2011年01期
5 褚万里;;我国交强险制度的成功与不足[J];道路交通管理;2010年08期
6 周书美;;论我国药品费用快速增长的原因与控制[J];内蒙古财经学院学报(综合版);2010年02期
7 田昕;宋雅然;张新平;;以系统理论分析国家基本药物制度[J];中国卫生事业管理;2010年04期
8 郑振Oz;;逐步解决公立医院“以药补医”的探讨[J];卫生经济研究;2010年01期
9 张领伟;罗鸣;;论交强险经营模式与道路救助基金职能[J];保险研究;2009年12期
10 吴年冬;;浅谈我国产品责任保险体系的构建[J];区域金融研究;2009年04期
,本文编号:1565053
本文链接:https://www.wllwen.com/jingjilunwen/bxjjlw/1565053.html